AstraZeneca may have used "outdated information" from vaccine trial: U.S. health agency
WASHINGTON, March 23 (Xinhua) -- Results from a U.S. trial of AstraZeneca's COVID-19 vaccine may have used "outdated information," a U.S. health agency said earlier Tuesday.
The Data and Safety Monitoring Board (DSMB) of the trial was concerned by information released by AstraZeneca on initial data from its COVID-19 vaccine clinical trial, said a statement of the U.S. National Institute of Allergy and Infectious Diseases (NIAID).